CAR-Immunotherapy PUBLISHED RESULTS

The CAR-Immunotherapy results file contains 12 parameters for 89 full papers, and lists 28 case reports, published through 30 June 2019.

For each publication, the following topics are covered:

  1. Trial ID
  2. Publication ID and link
  3. First/ last author and year of report
  4. Conditions
  5. CAR target
  6. Trial endpoints
  7. Number of patients (enrolled, infused, evaluable)
  8. Safety/ adverse events data
  9. Efficacy data
  10. CAR cells persistence in vivo
  11. Durability of response
  12. Were endpoints met?

Release 6 covers publications through 30 June 2019.

  • Total number of full papers increases by 8 from 81 to 89 publications.
  • 8 publications added (6 in liquid and 2 in solid malignancies)
  • 4 clinical cases added
  • one trial ID was not disclosed in publication
  • one trial has two IDs

Release 5 covers publications up to 31 Dec. 2018.

  • Total number of full papers increases by 12 from 69 to 81 publications.
  • 9 trials added
  • 9 publications added
  • 3 publications IDs (PMID) added to existent data (new papers analyzed different aspects of the same trial)
  • 2 clinical cases added

Release 4 covers publications up to 31 July 2018, including 9 full papers published in the first half of 2018.

  • 2 trial results were updated for liquid malignancies with data from the most recent publications (2018)
  • 4 more trials and 5 new full papers (one trial was not registered) were added to liquid malignancies
  • 2 more trials and 2 new full papers were added to solid malignancies
  • 4 more clinical case reports added (second tab)
  • changes from the previous update are highlighted in green

Timeline of CAR-Immunotherapy Trials versus Publications

Public samples: